• SELECT SITE CURRENCY
Select a currency for use throughout the site
Manpower Requirement for Biotech Industry in India
Cygnus Research, December 2005, Pages: 39
The field of biotechnology has seen some truly amazing developments in the last few decades. There are several factors, which makes the biotech scenario bright in India. Biotechnology especially, is gaining prominence in India & Asia Pacific region with many research institutions, university departments and corporate sector companies engaging in biotech research activities. It is indeed conducive for the growth of biotech as Indian scientists are gearing up to meet any challenge, especially after the completion of the Human Genome Project.
India's fledgling biotechnology industry registered a 39 percent growth in revenues in 2003- 04 to reach Rs 3,265 crore (US$ 705 million). With the industry zooming past the $1 billion mark, registering revenues of Rs 4,745 crore ($1.07 billion), a threshold has been crossed. The biotech industry continued to grow at almost the same rate that it did in the previous fiscal despite a growing base.
BioPharma is the single largest contributor to the total business primarily driven by the vaccines business. The BioServices sector is the next big market with nearly 9 percent market share with a major thrust from Clinical Trials and custom research. In the agri sector, transgenic crops, biopesticides and biofertilizers were considered along with biomarkers and agri research services. The other sectors considered included Industrial biotechnology mainly consisting of enzymes, and bioinformatics. The industry is expected to grow further to reach US$ 5 billion by 2010.
In order to match the growth rate of the industry the country has to prepare itself for providing sufficient manpower over the years. An estimate of the current available manpower in the industry in India is 11800. This figure has to increase over years matching the growth in the industry. This report is an attempt to assess the manpower requirement in the industry for the next five years across various sectors like biopharma, agri-biotech, bioservices, industrial biotech and bioinformatics.
2. APPROACH AND METHODOLOGY
2.1 Demand assessment
2.2 Supply estimation
3.1 Demand Side
3.2 Supply side
4. BIOTECHNOLOGY SECTORS
4.3 Industrial Biotechnology
5. GROSS DEMAND ASSESSMENT
6. SUPPLY OF MANPOWER IN THE INDUSTRY OVER YEARS
7. MANPOWER GAP ASSESSMENT
8. CONCLUSIONS AND RECOMMENDATIONS
Demand of Manpower over years (Industry-wise based on work profile)
Demand of manpower over years (Industry-wise based on educational qualification)
Supply of Manpower over years
India's fledgling biotechnology industry registered a 36percent growth in revenues in 2004-05 to cross the threshold US$ 1 Billion mark and is all set to reach US$ 5 Billion by 2010. Biopharma is the single largest contributor to the revenues, primarily driven by the vaccines business. The BioServices sector is the emerging sector, with a major thrust from Contract Research Outsourcing. The other major sectors considered for this study include agri biotech, industrial biotech, education and research. The following cart shows the changing demand for manpower in each sector over the next 5 years.
For each sector, a baseline manpower requirement was estimated per unit output and was validated with the current biotech manpower deployment patterns. Requirements for the next 5 years were arrived at by linking with the expected growth of each of the sectors. An analysis shows that share of biopharma requirements will increase from current 40 % of the total to 50% in 5 years. The highest growth of demand is expected in Bioservices, driven by clinical trials, contract research and contract manufacturing segments. As the industry matures, a significant part of technical manpower, especially from R&D organisations, will migrate to developed markets, thereby putting a pressure on the demand. It is estimated that about 73,000 biotech professionals will be needed in 5 years time, up from 11,800 biotech people deployed today.
An analysis of the intake of the students by the over 350 colleges shows that about 66,000 biotech professionals will be produced by the education system in 5 years. However, there is going to be significant gap with regard to qualified research professionals- with Ph.D. degrees, whereas there will be possibly be surplus of graduates, who may not be readily employable. The way to address this issue will be to offer vocational specializations like biopharma, clinical trials etc. Besides, there will be dearth of people with cross functional skills like techno commercial, techno legal etc, who will be required to handle functions like sales and marketing, legal and regulatory etc. This throws up demand for cross skilled programs like MBA (Biotechnology) and Law programs with focus on IPR and regulatory affairs.
A sample for this product is available. Please Login/Register to download this sample.